111 Inc
10 hedge funds and large institutions have $20.8M invested in 111 Inc in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
25% more funds holding
Funds holding: 8 → 10 (+2)
4% more capital invested
Capital invested by funds: $20M → $20.8M (+$799K)
0.01% less ownership
Funds ownership: 0.37% → 0.36% (-0.01%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TPM
Totem Point Management
New York
|
+$2.81M |
| 2 |
Millennium Management
New York
|
+$554K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$157K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$48.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$3.07M |
| 2 |
CIM
Chiron Investment Management
New York
|
-$195K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15.3K |
YI Hedge Fund Activity: Q1 2019 in Review
10 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in 111 Inc (YI) for Q1 2019, worth a combined $20.8M — up 4% from $20M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new YI positions and 1 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Totem Point Management, opening a new position worth an estimated $2.81M. The largest seller was OrbiMed, exiting entirely with an estimated $3.07M sold.
- 10 institutional investors held 111 Inc (YI) as of Q1 2019, up from 8 in Q4 2018.
- Funds reported $20.8M of 111 Inc stock for Q1 2019, up 4% quarter-over-quarter.
- 3 funds opened new 111 Inc positions in Q1 2019 and 1 closed out, a net change of +2 holders.
- The largest 111 Inc buyer in Q1 2019 was Totem Point Management, an estimated $2.81M added.
- The largest 111 Inc seller in Q1 2019 was OrbiMed, an estimated $3.07M sold.
Based on aggregated 13F filings for Q1 2019.